APRIL 14, 2013
Genetic Testing in Pain Medicine
We are beginning to recognize that, as is seen in much of medicine in the 21st century, genetics may explain the variability of responses and predict more effective (or less dangerous) medication choices. By identifying the genetic risks and the most effective analgesic for an individual patient, the clinician (at least theoretically) could improve the efficacy of the pain medication and decrease the risk for iatrogenically induced overdose, addiction, and death.
Listen to Dr. Trescot discuss genetic testing here.

Download to read this article in PDF format:

Genetic Testing in Pain Medicine

This article is in PDF format and it requires Adobe Reader. If you do not have Adobe Reader installed on your computer then pelase download and install from the link below.

Download Adobe Reader

More in Review Articles
Case Report 9: Considerations for Replacing Intrathecal Pumps at the End of a Device’s Life
Because these devices have been in use for over 20 years, ......
JANUARY 1, 2016
Nerve Injury After Peripheral Nerve Block: Best Practices and Medical-Legal Protection Strategies
The risk for permanent or severe nerve injury after peripheral ......
DECEMBER 31, 2015
Case Report 8: Ziconotide Delivered in a Novel Intrathecal Drug Delivery System
Intrathecal therapy continues to evolve concurrently with our ......
DECEMBER 30, 2015

The FDA is alerting health care professionals not to administer to patients compounded or repackaged...
Proton pump inhibitors have been associated with an increased risk for myocardial infarction, ...